Vitamin D receptor induces oxidative stress to promote esophageal squamous cell carcinoma proliferation via the p53 signaling pathway

被引:4
|
作者
Shang, Qi-Xin [1 ]
Zhang, Han -Lu [1 ]
Cheng, Ya-Ping [2 ]
Lu, Han [2 ]
Yuan, Yong [1 ]
Chen, Long-Qi [1 ]
Ji, Ai -Fang [2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Thorac Surg, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China
[2] Changzhi Med Univ, Heping Hosp, 161 Jiefang East St, Changzhi 046000, Peoples R China
关键词
Esophageal squamous cell carcinoma; VDR; Cell phenotype; TMT proteomics; p53 signaling pathway; Oxidative stress; Tumor formation in nude mice; COLON-CANCER; PROSTATE-CANCER; EXPRESSION; GENE; ASSOCIATION; POLYMORPHISM; METABOLISM; CALCIUM; GENOME; TISSUE;
D O I
10.1016/j.heliyon.2023.e23832
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Esophageal squamous cell carcinoma (ESCC) is a common pathological esophageal cancer with poor prognosis. Vitamin D deficiency reportedly occurs in ESCC patients, and this is related to single nucleotide polymorphism of vitamin D receptor (VDR).Objective: We investigated the effect of VDR on ESCC proliferation, invasion, and metastasis and its potential mechanism.Methods: ESCC and normal tissues were collected from 20 ESCC patients. The ESCC tissue microarray contained 116 pairs of ESCC and normal tissues and 73 single ESCC tissues. VDR expression and its clinicopathological role were determined by real-time quantitative polymerase chain reaction, Western blot, and immunohistochemistry staining. sh-VDR and VDR over-expression were used to validate the effect of VDR on ESCC cell phenotype, and tandem mass tag-based quantitative proteomics and bioinformatics methods identified differential VDR-related proteins. The downstream pathway and regulatory effect were analyzed using ingenuity pathway analysis (IPA). Differentially expressed proteins were verified through parallel reaction monitoring and Western blot. In vivo imaging visualized subcutaneous tumor growth following tail vein injection of VDR-deficient ESCC cells.Results: High VDR expression was observed in ESCC tissues and cells. Gender, T stage, and TNM stage were related to VDR expression, which was the independent prognostic factor related to ESCC. VDR downregulation repressed ESCC cell proliferation, invasion, and migration in vitro and subcutaneous tumor growth and lung metastases in vivo. The cell phenotype changes were reversed upon VDR upregulation, and differential proteins were mainly enriched in the p53 signaling pathway. TP53 cooperated with ABCG2, APOE, FTH1, GCLM, GPX1, HMOX1, JUN, PRDX5, and SOD2 and may activate apoptosis and inhibit oxidative stress, cell metastasis, and proliferation. TP53 was upregulated after VDR knockdown, and TP53 downregulation reversed VDR knockdown-induced cell phenotype changes.Conclusions: VDR may inhibit p53 signaling pathway activation and induce ESCC proliferation, invasion, and metastasis by activating oxidative stress.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Downregulation of GBAS regulates oral squamous cell carcinoma proliferation and apoptosis via the p53 signaling pathway
    Wang, Xing
    Bai, Yuting
    Han, Ying
    Meng, Jian
    Liu, Hongwei
    ONCOTARGETS AND THERAPY, 2019, 12 : 3729 - 3742
  • [2] SASS6 Promotes Proliferation of Esophageal Squamous Carcinoma Cells by Inhibiting the p53 Signaling Pathway
    Chen, Y.
    Zhu, K.
    Chen, J. Q.
    Xu, Y.
    Lin, L.
    Huang, Z.
    Zhang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E614 - E614
  • [3] SASS6 promotes proliferation of esophageal squamous carcinoma cells by inhibiting the p53 signaling pathway
    Xu, Yuanji
    Zhu, Kunshou
    Chen, Junqiang
    Lin, Liyan
    Huang, Zhengrong
    Zhang, Jiulong
    Chen, Yuanmei
    CARCINOGENESIS, 2021, 42 (02) : 254 - 262
  • [4] Accumulation of p53 in esophageal squamous cell carcinoma
    Chino, O
    Kijima, H
    Shimada, H
    Nishi, T
    Tanaka, H
    Kise, Y
    Kenmochi, T
    Himeno, S
    Machimura, T
    Tanaka, M
    Inokuchi, S
    Tajima, T
    Osamura, RY
    Makuuchi, H
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2001, 8 (04) : 359 - 363
  • [5] Inhibition of esophageal squamous cell carcinoma progression by MIR210HG and activation of the P53 signaling pathway to promote apoptosis and autophagy
    Jianyu Wang
    Zhenhu Zhang
    Liang Song
    Xiangyan Liu
    Xiaopeng He
    European Journal of Medical Research, 30 (1)
  • [6] Immunohistochemical Analysis of P53 and PRB in Esophageal Squamous Cell Carcinoma
    Dey, Biswajit
    Raphael, Vandana
    Khonglah, Yookarin
    Lynrah, Kyrshanlang Giri
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2014, 8 (05) : FC1 - FC3
  • [7] Nitrotyrosine in esophageal squamous cell carcinoma and relevance to p53 expression
    Kato, H
    Miyazaki, T
    Yoshikawa, M
    Nakajima, M
    Fukai, Y
    Tajima, K
    Masuda, N
    Tsutsumi, S
    Tsukada, K
    Nakajima, T
    Kuwano, H
    CANCER LETTERS, 2000, 153 (1-2) : 121 - 127
  • [8] Investigating the role of mutant p53 in esophageal squamous cell carcinoma
    Lento, Ashley
    Long, Apple
    Giroux, Veronique
    Tang, Qiaosi
    Sammons, Morgan
    Klein-Szanto, Andres
    Berger, Shelly
    Rustgi, Anil
    CANCER RESEARCH, 2017, 77
  • [9] Heterogeneity of p53 mutational status in esophageal squamous cell carcinoma
    Kuwabara, S
    Ajioka, Y
    Watanabe, H
    Hitomi, J
    Nishikura, K
    Hatakeyama, K
    JAPANESE JOURNAL OF CANCER RESEARCH, 1998, 89 (04): : 405 - 410
  • [10] No prognostic significance of p53 expression in esophageal squamous cell carcinoma
    Kanamoto, A
    Kato, H
    Tachimori, Y
    Watanabe, H
    Nakanishi, Y
    Kondo, H
    Yamaguchi, H
    Gotoda, T
    Muro, K
    Matsumura, Y
    JOURNAL OF SURGICAL ONCOLOGY, 1999, 72 (02) : 94 - 98